International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Latest Content
The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.
Advertisement
Advertisement
Trending on CURE
1
What Is a Personalized Cancer Vaccine? What Patients Should Know
2
Why Biomarker Testing Can Change a Brain Tumor Diagnosis
3
FDA Flags Possible Colitis Risk With CDK4/6 Breast Cancer Drugs
4
5 New Colorectal Cancer Clinical Trials to Know About
5